Patent ID: 8338362
Filing Date: 2012-12-25
Classification: A61K,A61P,C07D,C12N,Y02A

Abstract:
1. A method for the treatment of viral infection controllable by inhibiting SRPK enzymatic activity in a subject in need thereof comprising administering to the subject an effective inhibitory amount of an aniline derivative represented by the following formula (I): or a pharmaceutically acceptable salt or hydrate thereof; wherein, R R R R Q represents —C(O)—, —C(S)—, —SO W represents a hydrogen atom, a C wherein, R 5 and R 6 are the same or different and each represents a hydrogen atom, a C 1-6 alkyl group which may have a substituent, a nitrogen-containing heterocycle which may have a substituent, a condensed aromatic heterocycle which may have a substituent, an acyl group, or an acylamino group; the above R the above R wherein the SRPK is SRPK1 or SRPK2.